Cited by 43Pancreatic function and diabetesRenin-Angiotensin System StudiesDiabetes Treatment and Management

The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis

Open access
Graus-Nunes, Francielle, Souza-Mello, Vanessa·2019·Biomedicine & Pharmacotherapy

Abstract

Local renin-angiotensin system (RAS) in the pancreas is linked to the modulation of glucose-stimulated insulin secretion (GSIS) in beta cells and insulin sensitivity in target tissues, emerging as a promising tool in the prevention and/or treatment of obesity, diabetes, and systemic arterial hypertension. Insulin resistance alters pancreatic islet cell distribution and morphology and hypertrophied islets exhibit upregulated angiotensin II type 1 receptor, which drives oxidative stress, apoptosis, and fibrosis, configuring beta cell dysfunction and diminishing islet lifespan. Pharmacological modulation of RAS has shown beneficial effects in diet-induced obesity model, mainly related to the translational potential that angiotensin receptor blockers and ECA2/ANG (1-7)/MAS receptor axis modulation have when it comes to islet preservation and type 2 diabetes prevention and/or treatment. This review describes the existing evidence for different approaches to blocking RAS elements in the management of insulin resistance and diabetes and focuses on islet remodeling and GSIS in rodents and humans.

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2018.10.191

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 75 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Graus-Nunes, F., & Souza-Mello, V.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2019-01
Volume
109
Pages
639-645
ISSN
0753-3322 (ISSN-L)
OpenAlex
W2898669007
Cited by
43
References
75
Citations by year
2026: 1 · 2025: 6 · 2024: 10 · 2023: 3 · 2022: 6 · 2021: 8 · 2020: 7 · 2018: 2
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
renin-angiotensin system, endocrine pancreas, beta-cell function, glucose-stimulated insulin secretion, insulin resistance, type 2 diabetes, angiotensin II type 1 receptor, angiotensin-(1-7), Mas receptor, angiotensin receptor blockers, islet fibrosis, oxidative stress, beta-cell apoptosis, obesity
MeSH terms
Angiotensin I, Angiotensin II, Angiotensin-Converting Enzyme Inhibitors, Animals, Homeostasis, Humans, Insulin Resistance, Islets of Langerhans, Peptide Fragments, Renin-Angiotensin System, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review